Thomas Lorey

6.4k total citations · 1 hit paper
107 papers, 4.0k citations indexed

About

Thomas Lorey is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Thomas Lorey has authored 107 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Epidemiology, 42 papers in Surgery and 32 papers in Oncology. Recurrent topics in Thomas Lorey's work include Cervical Cancer and HPV Research (80 papers), Genital Health and Disease (31 papers) and Global Cancer Incidence and Screening (19 papers). Thomas Lorey is often cited by papers focused on Cervical Cancer and HPV Research (80 papers), Genital Health and Disease (31 papers) and Global Cancer Incidence and Screening (19 papers). Thomas Lorey collaborates with scholars based in United States, Canada and Germany. Thomas Lorey's co-authors include Nancy Poitras, Philip E. Castle, Walter Kinney, Barbara Fetterman, Mark Schiffman, Li C. Cheung, Hormuzd A. Katki, Nicolas Wentzensen, Julia C. Gage and Tina Raine‐Bennett and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Thomas Lorey

103 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

2011 412 citations Hormuzd A. Katki, Walter Kinney et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Lorey United States	38	3.3k	1.7k	1.2k	552	500	107	4.0k
Julia C. Gage United States	43	4.1k 1.2×	1.8k 1.1×	1.5k 1.2×	564 1.0×	607 1.2×	122	4.9k
Ann Moriarty United States	23	3.2k 1.0×	1.4k 0.9×	1.3k 1.1×	481 0.9×	452 0.9×	89	4.2k
Levi S. Downs United States	30	2.8k 0.8×	1.4k 0.8×	1.7k 1.4×	946 1.7×	548 1.1×	80	4.9k
Karl Ulrich Petry Germany	30	3.3k 1.0×	1.6k 1.0×	1.1k 0.9×	574 1.0×	692 1.4×	101	4.3k
Pekka Nieminen Finland	38	3.3k 1.0×	1.1k 0.6×	1.4k 1.1×	767 1.4×	813 1.6×	133	4.5k
Diane D. Davey United States	28	2.9k 0.9×	1.3k 0.8×	944 0.8×	385 0.7×	329 0.7×	122	3.7k
Massimo Confortini Italy	27	3.0k 0.9×	1.4k 0.9×	1.2k 1.0×	366 0.7×	523 1.0×	94	3.6k
Christine Bergeron France	40	3.5k 1.1×	1.7k 1.0×	999 0.8×	1.2k 2.2×	651 1.3×	99	5.1k
George Koliopoulos Greece	21	3.7k 1.1×	1.5k 0.9×	1.1k 0.9×	897 1.6×	505 1.0×	57	4.1k
Mark Spitzer United States	22	3.8k 1.1×	1.6k 1.0×	1.4k 1.1×	777 1.4×	472 0.9×	77	4.6k

Countries citing papers authored by Thomas Lorey

Since Specialization

Citations

This map shows the geographic impact of Thomas Lorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lorey more than expected).

Fields of papers citing papers by Thomas Lorey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lorey. The network helps show where Thomas Lorey may publish in the future.

Co-authorship network of co-authors of Thomas Lorey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lorey. A scholar is included among the top collaborators of Thomas Lorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lorey. Thomas Lorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nelson, Chase W., Meredith Yeager, Zigui Chen, et al.. (2025). Whole‐genome sequencing of 1,083 HPV45 cases and controls identifies genetic variants associated with glandular cervical lesions. International Journal of Cancer. 157(6). 1130–1141.

Massad, L. Stewart, Megan A. Clarke, Rebecca B. Perkins, et al.. (2025). Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines. Journal of Lower Genital Tract Disease. 29(2). 134–143. 10 indexed citations

Lorey, Thomas, Jeffrey M. Schapiro, Elizabeth Suh‐Burgmann, et al.. (2024). Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs. Journal of Molecular Diagnostics. 26(6). 487–497. 4 indexed citations

Pinheiro, Maísa, Nicolas Wentzensen, Michael Dean, et al.. (2024). Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type. Nature Communications. 15(1). 7895–7895. 4 indexed citations

Madison, Bereneice M., et al.. (2023). Effective Access to Laboratory Test Results: A Health Equity Issue that Enhances Diagnostic Excellence. The Journal of Applied Laboratory Medicine. 8(3). 635–644. 7 indexed citations

Shah, Nina R., Barbara Fetterman, Nancy Poitras, et al.. (2021). Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result. Obstetrics and Gynecology. 138(4). 580–581.

Dawson, Eric T., Sarah Wagner, David A. Roberson, et al.. (2019). Viral coinfection analysis using a MinHash toolkit. BMC Bioinformatics. 20(1). 389–389. 2 indexed citations

Clarke, Megan A., Ana Gradíssimo, Mark Schiffman, et al.. (2018). Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women. Clinical Cancer Research. 24(9). 2194–2202. 77 indexed citations

Silver, Michelle I., Julia C. Gage, Mark Schiffman, et al.. (2018). Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years. Cancer Prevention Research. 11(3). 165–170. 31 indexed citations

10.

Castle, Philip E., Xianhong Xie, Xiaonan Xue, et al.. (2018). Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Preventive Medicine. 118. 44–50. 21 indexed citations

11.

Rendle, Katharine A., Mark Schiffman, Li C. Cheung, et al.. (2017). Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting. Preventive Medicine. 109. 44–50. 13 indexed citations

12.

Castle, Philip E., Walter Kinney, Li C. Cheung, et al.. (2017). Why does cervical cancer occur in a state-of-the-art screening program?. Gynecologic Oncology. 146(3). 546–553. 48 indexed citations

13.

Wentzensen, Nicolas, Barbara Fetterman, Philip E. Castle, et al.. (2015). p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. JNCI Journal of the National Cancer Institute. 107(12). djv257–djv257. 136 indexed citations

14.

Schwartz, Lauren M., Philip E. Castle, Stephen Follansbee, et al.. (2013). Risk Factors for Anal HPV Infection and Anal Precancer in HIV-Infected Men Who Have Sex With Men. The Journal of Infectious Diseases. 208(11). 1768–1775. 52 indexed citations

15.

Katki, Hormuzd A., Mark Schiffman, Philip E. Castle, et al.. (2013). Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results. Journal of Lower Genital Tract Disease. 17(Supplement 1). S43–S49. 45 indexed citations

16.

Katki, Hormuzd A., Mark Schiffman, Philip E. Castle, et al.. (2013). Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive. Journal of Lower Genital Tract Disease. 17(Supplement 1). S56–S63. 67 indexed citations

17.

Fetterman, Barbara, et al.. (2013). Risk of Cervical Precancer and Cancer in Women With Cervical Intraepithelial Neoplasia Grade 1 on Endocervical Curettage. Journal of Lower Genital Tract Disease. 17(3). 255–260. 5 indexed citations

18.

Castle, Philip E., Stephen Follansbee, Diane Tokugawa, et al.. (2012). A Comparison of Human Papillomavirus Genotype-Specific DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men. Cancer Epidemiology Biomarkers & Prevention. 22(1). 42–49. 20 indexed citations

19.

Greene, Dina N., et al.. (2012). Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. Clinica Chimica Acta. 413(15-16). 1232–1238. 45 indexed citations

20.

Fetterman, Barbara, J. Thomas Cox, Nancy Poitras, et al.. (2010). Lessons From Practice. Journal of Lower Genital Tract Disease. 14(2). 97–102. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact